| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8725474 | Clinics and Research in Hepatology and Gastroenterology | 2018 | 8 Pages |
Abstract
ETV leads to an early response on HBV DNA decline in the first year of the treatment. However, TDF is more successful than entecavir in achieving virological suppression.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Bircan Kayaaslan, Esragul Akinci, Alpay Ari, Zeliha Kocak Tufan, Saygın Nayman Alpat, Ozgur Gunal, Selma Tosun, Rahmet Guner, Fehmi Tabak,